Filed: 5/9/2024ACC: 0000895345-24-000166
📋 What this filing means
ALERCE INVESTMENT MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $95.08M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$95.08M
Total AUM (reported)
33.55M
Total Shares
Allocation by class
COM$81.08M85.3%
CL A$8.49M8.9%
COM NEW$5.51M5.8%
Portfolio Concentration
Top 3$85.76M90.2%
4–10$9.32M9.8%
Top 3 weight
90.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 33.55M
Sole
Full voting authority
33.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ANNEXON INC
SOLEShares7.41M
TypeSH
Market value$53.10M
55.85%
Sole
7.41M
Shared
0.00
None
0.00
AKEBIA THERAPEUTICS INC
SOLEShares13.21M
TypeSH
Market value$24.17M
25.42%
Sole
13.21M
Shared
0.00
None
0.00
AMERICAN WELL CORP
SOLEShares10.48M
TypeSH
Market value$8.49M
8.93%
Sole
10.48M
Shared
0.00
None
0.00
AILERON THERAPEUTICS INC
SOLEShares830.47K
TypeSH
Market value$5.51M
5.79%
Sole
830.47K
Shared
0.00
None
0.00
AADI BIOSCIENCE INC
SOLEShares1.63M
TypeSH
Market value$3.82M
4.01%
Sole
1.63M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ANNEXON INCSOLE | COM | 7.41M | SH | $53.10M 55.85% | 7.41M | 0.00 | 0.00 |
AKEBIA THERAPEUTICS INCSOLE | COM | 13.21M | SH | $24.17M 25.42% | 13.21M | 0.00 | 0.00 |
AMERICAN WELL CORPSOLE | CL A | 10.48M | SH | $8.49M 8.93% | 10.48M | 0.00 | 0.00 |
AILERON THERAPEUTICS INCSOLE | COM NEW | 830.47K | SH | $5.51M 5.79% | 830.47K | 0.00 | 0.00 |
AADI BIOSCIENCE INCSOLE | COM | 1.63M | SH | $3.82M 4.01% | 1.63M | 0.00 | 0.00 |